1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Stentys
  6. Company
    STNT   FR0010949404

STENTYS

(STNT)
End-of-day quote Euronext Paris  -  2019-07-21
0.4600 EUR   -2.95%
2020Stentys S.A. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
2020STENTYS : Financial Information for the First Quarter Of 2020
BU
2020STENTYS S.A. Announces Revenue Results for the First Quarter Of 2020
CI
SummaryQuotesChartsNewsCompany 
Business Summary
Stentys SA is a French-based company specialized in the development of a new generation of stents for the treatment of acute myocardial infarction or coronary artery disease. It's main product STENTYS Stent, self-expanding coronary bare-metal stent system, is indicated for the treatment of Acute Coronary Syndrome. The Company's institutional shareholders are Sofinnova Partners, Credit Agricole Private Equity and Scottish Equity Partners. In June 2014, it acquired Cappella Peel Away Inc.
Managers
Name Title Age Since
Michel Darnaud Chairman & Chief Executive Officer 71 2019
André Lerebours Chief Financial Officer & Deputy CEO - -
Marco Gario Vice President-International Sales - 2011
Tom Coles Vice President-Marketing & Communication - 2018
Alain Delabost Vie President-International Sales - 2018
Luc Demangeon Vice President-Regulatory, Quality & Clinical - 2018
Members of the board
Name Title Age Since
Michel Darnaud Chairman & Chief Executive Officer 71 2019
Marie Meynadier, Dr. Independent Director 60 2014
Sophie Baratte, Dr. Independent Director 58 2017
Christian M. Spaulding, Dr. Independent Director 65 2017
Gilles Montalescot Member-Scientific Committee - -
Raoul Bonan Member-Scientific Committee - -
Thierry Lefèvre Member-Scientific Committee - -
Patrick Serruys Member-Scientific Committee - -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 26,824,657 26,805,915 99.9% 18,742 0.1% 99.9%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Stentys
Sector Other Medical Equipment, Supplies & Distribution
1st jan.Capi. (M$)
STENTYS0.00%17
ABBOTT LABORATORIES-23.99%187 298
MEDTRONIC PLC-13.77%118 521
BECTON, DICKINSON AND COMPANY-0.50%69 707
BAXTER INTERNATIONAL INC.-23.99%32 855
HOYA CORPORATION-29.69%32 074
AMERISOURCEBERGEN CORPORATION12.29%29 993
SARTORIUS STEDIM BIOTECH-37.09%29 445
DEXCOM, INC.-44.35%29 320
TERUMO CORPORATION-15.41%22 817
ZIMMER BIOMET HOLDINGS-14.46%22 316
WEST PHARMACEUTICAL SERVICES, INC.-35.01%21 960
FUJIFILM HOLDINGS CORPORATION-14.44%21 456
STERIS PLC-15.96%20 471
AVANTOR, INC.-24.96%19 299
ALIGN TECHNOLOGY, INC.-63.19%19 065
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.7.81%18 596
INSULET CORPORATION-14.98%15 685
BIO-RAD LABORATORIES, INC.-34.47%14 707
SYSMEX CORPORATION-47.11%12 628
TELEFLEX INCORPORATED-22.90%11 878